Market›Materials›Chemicals›Specialty Chemicals
NOVONESIS A S Class B

NVZMF

$61.00Apr 26, 2021 – Apr 24, 2026
MaterialsChemicalsSpecialty Chemicals$28.89B
MVM
+$28.89B
TD Variance
0.073

Every news event mapped to its market reaction — 46 events, 61 months of data. No predictions, just what happened.

PositiveNegativeNo data· Dot size = magnitude · Scroll to zoom · Drag to pan
Hover to inspect

Want the full written briefing?

The chart shows what moved — the briefing shows why. Sourced, dated, no hot takes.

Subscribe on Substack →

News Events

DateReturnCategorySourceHeadline
2025-02-26+8.3%earningsSeeking AlphaNovonesis A/S (NVZMF) Q4 2024 Earnings Call Transcript
2025-02-26+8.3%earningsSeeking AlphaNovonesis A/S 2024 Q4 - Results - Earnings Call Presentation
2025-02-26+8.3%newsSeeking AlphaNovonesis A/S reports FY results
2025-11-06+8.2%earningsSeeking AlphaNovozymes A/S reports Q3 results
2025-11-06+8.2%earningsSeeking AlphaNovozymes A/S (NVZMY) Q3 2025 Earnings Call Transcript
2025-11-06+8.2%earningsSeeking AlphaNovozymes A/S 2025 Q3 - Results - Earnings Call Presentation
2025-11-06+8.2%earningsYahoo FinanceNovonesis (Novozymes) B (NVZMF) Q3 2025 Earnings Call Highlights: Strong Growth in Emerging ... - Yahoo Finance
2024-05-03+7.8%earningsSeeking AlphaNovozymes A/S (NVZMF) Q1 2024 Trading Statement Earnings Call Transcript
2024-05-03+7.8%earningsSeeking AlphaQ1 trading statement
2026-02-25-7.0%earningsGuruFocus.comNovonesis (Novozymes) B (NVZMF) Full Year 2025 Earnings Call Highlights: Strong Organic Sales ...
2026-02-25-7.0%earningsSeeking AlphaNovozymes A/S Non-GAAP EPS of 1.49, revenue of 4.16B
2026-02-25-7.0%earningsSeeking AlphaNovozymes A/S (NVZMY) Q4 2025 Earnings Call Transcript
2026-02-25-7.0%earningsSeeking AlphaNovozymes A/S 2025 Q4 - Results - Earnings Call Presentation
2025-08-21-6.5%earningsSeeking AlphaNovonesis A/S (NVZMF) Q2 2025 Earnings Call Transcript
2025-08-21-6.5%earningsSeeking AlphaNovozymes A/S 2025 Q2 - Results - Earnings Call Presentation
2025-08-21-6.5%earningsSeeking AlphaNovozymes A/S Non-GAAP EPS of 0.78, revenue of 2.09B
2025-05-09+5.1%earningsSeeking AlphaNovonesis A/S GAAP EPS of 0.40, revenue of 1.08B
2026-02-16-4.7%newsSimply Wall St.Is Novozymes (CPSE:NSIS B) Pricing Reflect Recent Valuation Concerns Accurately
2025-06-01+4.2%newsSeeking AlphaNovonesis: Industry Leader With Defensive Characteristics And Solid Growth
2025-06-01+4.2%newsSeeking AlphaNovonesis: Industry Leader With Defensive Characteristics And Solid Growth - Seeking Alpha
2024-06-28-4.1%M&ASeeking AlphaChr. Hansen: Outperformance After The Merger And New Novonesis
2024-06-28-4.1%M&ASeeking AlphaChr. Hansen: Outperformance After The Merger And New Novonesis (OTCMKTS:CHYHY) - Seeking Alpha
2024-11-10-3.8%newsSeeking AlphaNVZMF 9M_2024_Conference_call_slides
2024-11-10-3.8%earningsSeeking AlphaNovonesis A/S (NVZMF) Q3 2024 Earnings Call Transcript
2026-02-26+3.7%newsGlobeNewswireTrading by management and close relations of management
2026-02-26+3.7%newsGlobeNewswireInvitation to the 2026 Annual General Meeting
2025-05-11-3.3%earningsSeeking AlphaNovonesis A/S (NVZMF) Q1 2025 Earnings Call Transcript
2026-04-16-3.2%newsZacksFUL vs. NVZMY: Which Stock Should Value Investors Buy Now?
2026-03-23+2.9%newsGlobeNewswireResolutions from the Annual General Meeting 2026
2026-03-23+2.9%analystSeeking AlphaNovozymes A/S (NVZMY) Shareholder/Analyst Call Transcript
2024-11-08-2.4%analystSeeking AlphaNovonesis: Underperformance In Price, But Now I'm Buying (Rating Upgrade)
2024-11-08-2.4%newsSeeking AlphaNovonesis Stock: Underperformance In Price, But Now I'm Buying (NVZMF) - Seeking Alpha
2026-03-27+2.2%analystSeeking AlphaNovozymes A/S (NVZMY) Shareholder/Analyst Call - Slideshow
2024-08-28-2.2%earningsSeeking AlphaNovozymes A/S (NVZMF) Q2 2024 Earnings Call Transcript
2024-08-28-2.2%newsSeeking AlphaNovozymes A/S reports 1H results
2026-02-09-2.1%newsGlobeNewswireSynthetic Biology and Bioprocessing Market Reaches Multi-Billion Scale with High-Throughput Fermentation and Engineered Microbes Driving Innovation
2026-03-31+1.3%newsZacksFUL or NVZMY: Which Is the Better Value Stock Right Now?
2023-12-21-1.2%M&ASeeking AlphaNovozymes: Becoming A Global Leader In Bio-Solutions With Chr. Hansen Merger
2024-03-06+1.1%newsSeeking AlphaNovonesis: A New Beginning For Novozymes And Christian Hansen
2024-03-06+1.1%newsSeeking AlphaNovonesis: A New Beginning For Novozymes And Christian Hansen (OTCMKTS:NVZMF) - Seeking Alpha
2025-02-06+1.0%newsSeeking AlphaNovonesis: Still Too Expensive
2025-02-06+1.0%newsSeeking AlphaNovonesis: Still Too Expensive (NVZMF) - Seeking Alpha
2026-04-04-0.7%newsSimply Wall St.Novozymes Dividend Increase And Valuation Discount Catch Investor Attention
2024-02-01+0.4%earningsSeeking AlphaNovozymes A/S (NVZMF) Q4 2023 Earnings Call Transcript
2024-02-01+0.4%earningsSeeking AlphaNovozymes A/S 2023 Q4 - Results - Earnings Call Presentation
2026-02-05+0.4%M&AZacksCabot Expands Mexico Footprint With MXCB Facility Buyout
tickerdossier.comtickerdossier.substack.com